6919 KangPei* Announcement of Lifting Non-Compete Restrictions for Independent Director
KangPei (6919) announced that the shareholders' meeting on May 22, 2026, approved the lifting of non-compete restrictions for Independent Director Luo Bao-Zhu, who serves on other biotech boards.
📋 Article Processing Timeline
- 📰 Published: May 23, 2026 at 06:31
- 🔍 Collected: May 23, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 31, 2026 at 21:02 (206h 30m after Collected)
On May 22, 2026, KangPei Biotech Co., Ltd. held a shareholders' meeting and approved the resolution to lift the non-compete restrictions for Independent Director Luo Bao-Zhu. Luo currently serves as an independent director at both Everfront Biotech Inc. and PharmaEngine, Inc. The resolution was passed in accordance with Article 209 of the Company Act.
FAQ
Who is the non-compete restriction lifted for?
Independent Director Luo Bao-Zhu.